PTC THERAPEUTICS INC
PTCTNASDAQ🏆 #1249 by market capEarnings Oct 22 · PostUS Equity
$64.96▼ $0.97 (−1.50%)
🌙 After hours$64.96▲ 0.00%Regular close · extended-hours price shownTrack PTCT
Get earnings, price moves & breaking news on Telegram
24h▼ 1.5%
7d▼ 1.5%
14d▼ 1.1%
30d▼ 7.2%
ytd▼ 14.5%
1y▲ 7.1%
🏦Market Cap
$5.39B
Small Cap
📈Revenue Growth (YoY)
-42.8%
Declining
📊Gross Margin
93.0%
High
💵FCF Margin
12.6%
Healthy
⚖️P/S Ratio
5.2x
Fair
Otter Score
52
Weak
PTC THERAPEUTICS INC
PTCTAnalyst Ratings
Price
$64.96
Total
26
Raised
4
Lowered
4
Avg PT
$106.00
H / L
$137 / $85
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Cantor Fitzgerald | Reiterated | Overweight | 2026-09-22 | $137.00 | +110.90% |
Barclays | Reiterated | Overweight | 2026-08-14 | $122.00 | +87.80% |
Wells Fargo | Reiterated | Overweight | 2026-08-13 | $109.00 | +67.80% |
Morgan Stanley | Reiterated | Overweight | 2026-07-31 | $104.00 | +60.10% |
RBC Capital | Reiterated | Sector Perform | 2026-07-07 | $85.00 | +30.80% |
Jefferies | Upgraded | Hold → Buy | 2026-05-27 | $85.00 | +30.80% |
TD Cowen | Upgraded | Hold → Buy | 2026-05-08 | — | — |
B of A Securities | Reiterated | Buy | 2026-02-20 | — | — |
Goldman Sachs | Reiterated | Sell | 2025-11-05 | $50.00 | −23.00% |
Citigroup | Reiterated | Neutral | 2025-11-05 | — | — |
UBS | Reiterated | Buy | 2025-07-29 | $47.00 | −27.60% |
Truist Securities | Reiterated | Buy | 2025-07-29 | — | — |
JP Morgan | Reiterated | Overweight | 2025-05-07 | — | — |
Baird | Reiterated | Outperform | 2025-05-07 | — | — |
Raymond James | Downgraded | Outperform → Underperform | 2023-09-18 | $108.00 | +66.30% |
Credit Suisse | Reiterated | Neutral | 2023-07-20 | — | — |
SVB Leerink | Reiterated | Market Perform → Perform | 2023-03-17 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-07-21 | — | — |
Bank of America | Upgraded | Neutral → Buy | 2019-05-13 | — | — |
Bernstein | Reiterated | Outperform | 2019-04-11 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2018-06-18 | — | — |
Wedbush | Downgraded | Outperform → Neutral | 2016-03-01 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2016-03-01 | — | — |
Oppenheimer | Reiterated | Outperform | 2016-02-25 | — | — |
Roth Capital | Downgraded | Buy → Neutral | 2015-05-05 | — | — |
Deutsche Bank | Reiterated | Buy | 2015-04-09 | — | — |
Institution
Cantor Fitzgerald
Reiterated · Overweight · 2026-09-22
$137.00
+110.90%
Barclays
Reiterated · Overweight · 2026-08-14
$122.00
+87.80%
Wells Fargo
Reiterated · Overweight · 2026-08-13
$109.00
+67.80%
Morgan Stanley
Reiterated · Overweight · 2026-07-31
$104.00
+60.10%
RBC Capital
Reiterated · Sector Perform · 2026-07-07
$85.00
+30.80%
Jefferies
Upgraded · Hold → Buy · 2026-05-27
$85.00
+30.80%
TD Cowen
Upgraded · Hold → Buy · 2026-05-08
—
—
B of A Securities
Reiterated · Buy · 2026-02-20
—
—
Goldman Sachs
Reiterated · Sell · 2025-11-05
$50.00
−23.00%
Citigroup
Reiterated · Neutral · 2025-11-05
—
—
UBS
Reiterated · Buy · 2025-07-29
$47.00
−27.60%
Truist Securities
Reiterated · Buy · 2025-07-29
—
—
JP Morgan
Reiterated · Overweight · 2025-05-07
—
—
Baird
Reiterated · Outperform · 2025-05-07
—
—
Raymond James
Downgraded · Outperform → Underperform · 2023-09-18
$108.00
+66.30%
Credit Suisse
Reiterated · Neutral · 2023-07-20
—
—
SVB Leerink
Reiterated · Market Perform → Perform · 2023-03-17
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-07-21
—
—
Bank of America
Upgraded · Neutral → Buy · 2019-05-13
—
—
Bernstein
Reiterated · Outperform · 2019-04-11
—
—
William Blair
Upgraded · Market Perform → Outperform · 2018-06-18
—
—
Wedbush
Downgraded · Outperform → Neutral · 2016-03-01
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2016-03-01
—
—
Oppenheimer
Reiterated · Outperform · 2016-02-25
—
—
Roth Capital
Downgraded · Buy → Neutral · 2015-05-05
—
—
Deutsche Bank
Reiterated · Buy · 2015-04-09
—
—
One row per institution · price target from the firm's latest published target